NHS England’s surprise decision to hand US tech giant Palantir a further £25m deal this week without a competitive process provoked a mixture of fury and confusion. We explain what the new contract means and why its so controversial.
Also this week, we review the latest government mandate for NHS England and its luke-warm response to the Hewitt review of integrated care systems.
